Priced at approximately $350 for a 15mg vial
These drugs fall within two categories: human GLP-1 backbone agents (that is, albiglutide, dulaglutide, liraglutide and semaglutide) and exendin-4 backbone agents (that is, exenatide, lixisenatide and tirzepatidethe latter activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors) 1
Support natural hormone balance, improved metabolism, and deeper recovery with personalized peptide therapy plans from PureIV
If weight loss treatment is part of your healthcare plan and medically necessary, FSA dollars provide an immediate tax break without the investment restrictions of an HSA
Author: Jennifer Walker, RN, MSN, NPD-BC, GERO-BC, NE-BC References: Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J